Logo Img
Logo Img Logo Img
  • Home
    • Platform
    • Services
    • Brands
    • Locations
    • Careers
    • News
    • Library
    • Responsibility
    • Contact Us
  • Platform
    • Our Platform
    • Our Competitive Edge
  • Services
    • Preclinical Development
    • Clinical Development
    • Regulatory Affairs & Consulting
    • Data Sciences
    • Molecular Laboratory R&D Services
    • Microbiology and Diagnostics R&D Services
  • Brands
    • Clinglobal
      • About us
      • Our Services
      • Our Team
    • Clinvet
      • About us
      • Our Services
      • Our Team
    • Clindata
      • About us
      • Our Services
      • Our Team
    • Clinomics
      • About us
      • Our Services
      • Our Team
    • Clinaxel
    • Rtilab
  • Locations
  • Careers
  • News
    • Social Media
  • Library
    • Research Models
    • Publications
  • Responsibility
    • Our Purpose
    • Our Values
    • Corporate Responsibility
    • Compliance
  • Contact us

[contact-form-7 id=”aa96f92″ title=”Themeht-Menu-Form”]

+123 456 789

[email protected]

Vectra 3D (dinotefuran, pyriproxyfen and permethrin) prevents acquisition of Borrelia burgdorferi sensu stricto by Ixodes ricinus and Ixodes scapularis ticks in an ex vivo feeding model

  1. Home
  2. Vectra 3D (dinotefuran, pyriproxyfen and permethrin) prevents acquisition of Borrelia burgdorferi sensu stricto by Ixodes ricinus and Ixodes scapularis ticks in an ex vivo feeding model
  • digitalplatforms
  • April 25, 2025
  • 0 Comments
File Type: pdf
File Size: 4 MB
Categories: Publications

Post navigation

Previous
Vaccination with a multivalent modified-live virus vaccine administered one year prior to challenge with BVDv1a and 2a in pregnant heifers_The Bovine Practitioner 2013 Zim
Next
WAAVP Second edition of Guideline for evaluating the efficacy of parasiticides against ectoparasites of ruminants

Search

Categories

  • Clinglobal
  • Uncategorized

Recent News

  • Clinglobal Welcomes Schafer Veterinary Consultants to the Clinaxel Team! Apr 04, 2025
  • Introducing Clinaxel: the new Field Clinical Trials and Regulatory Affairs business unit from Clinglobal Group. Dec 01, 2024
  • Clinglobal Welcomes OCRvet to the Team! Oct 02, 2024
Quick Links
  • About Us
  • Research Models
  • Locations
  • Contact Us
Services
  • Clinical Development
  • Data Sciences
  • Regulatory Affairs & Consulting
  • Molecular Laboratory R&D Services
  • Pre-Clinical Development
  • Microbiology and Diagnostics R&D Services
Compliance
  • PAIA Manual
  • Privacy Notice
Footer Image
Copyright © 2024 All Rights Reserved | Clinglobal | Developed by Digital Platforms